Series B Completed
NRG Therapeutics Series B
£50m raised
Announced 8 Sep 2025
Investors
Led by
- SV Health Investors · through Dementia Discovery Fund
With
- British Business Bank
- M Ventures
- Novartis Venture Fund
- Criteria Bio Ventures
- Omega Fund Management · Existing investor
- Brandon Capital Partners · Existing investor
- Parkinson’s UK · Existing investor
Investors as the sources name them; a linked name has a FundComb profile. An existing investor is one the source says followed on.
- Company
- NRG Therapeutics
- Stage
- Series B
- Amount raised
- £50m
- Company based in
- United Kingdom
Similar rounds
- Heidi Series B Oct 2025 · A$100m · led by Point72
- Foxglove Series B 2025 · A$63.9m
- Agentio Series B Nov 2025 · A$61.1m · led by Forerunner Ventures
- ENA Respiratory Series B Oct 2025 · A$34.5m
- Ivo Series B Jan 2026 · A$83.8m · led by Blackbird Ventures
Sources
- 8 Sep 2025 NRG Therapeutics announces oversubscribed £50m ($67m) Series B financing brandoncapital.vc
- 9 Sep 2025 NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing brandonbiocatalyst.com